KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Capital Expenditures (2020 - 2025)

Oscar Health (OSCR) has disclosed Capital Expenditures for 6 consecutive years, with $9.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 32.89% year-over-year to $9.1 million, compared with a TTM value of $36.4 million through Dec 2025, up 30.38%, and an annual FY2025 reading of $36.4 million, up 30.38% over the prior year.
  • Capital Expenditures was $9.1 million for Q4 2025 at Oscar Health, up from $9.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $9.6 million in Q3 2022 and bottomed at $5.6 million in Q2 2023.
  • Average Capital Expenditures over 5 years is $7.2 million, with a median of $7.0 million recorded in 2022.
  • The sharpest move saw Capital Expenditures soared 117.24% in 2021, then plummeted 32.63% in 2023.
  • Year by year, Capital Expenditures stood at $7.2 million in 2021, then dropped by 1.05% to $7.1 million in 2022, then decreased by 14.42% to $6.1 million in 2023, then grew by 11.75% to $6.8 million in 2024, then soared by 32.89% to $9.1 million in 2025.
  • Business Quant data shows Capital Expenditures for OSCR at $9.1 million in Q4 2025, $9.0 million in Q3 2025, and $9.3 million in Q2 2025.